Atomistry » Chlorine » PDB 3th4-3tnn » 3thb
Atomistry »
  Chlorine »
    PDB 3th4-3tnn »
      3thb »

Chlorine in PDB 3thb: Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor

Enzymatic activity of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor

All present enzymatic activity of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor:
2.7.11.21;

Protein crystallography data

The structure of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor, PDB code: 3thb was solved by M.D.Sintchak, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.00 / 2.50
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 67.668, 67.668, 154.684, 90.00, 90.00, 120.00
R / Rfree (%) 25 / 28.6

Other elements in 3thb:

The structure of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor (pdb code 3thb). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor, PDB code: 3thb:

Chlorine binding site 1 out of 1 in 3thb

Go back to Chlorine Binding Sites List in 3thb
Chlorine binding site 1 out of 1 in the Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of PLK1 Kinase Domain in Complex with A Benzolactam-Derived Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1

b:0.0
occ:1.00
 CL1 A:3TA1 0.0 0.0 1.0
C13 A:3TA1 1.7 0.8 1.0
C12 A:3TA1 2.7 0.5 1.0
C14 A:3TA1 2.7 97.9 1.0
C A:LYS61 3.5 0.8 1.0
N A:LYS61 3.5 0.7 1.0
C A:GLY60 3.5 99.2 1.0
O A:LYS61 3.7 0.1 1.0
N A:GLY62 3.7 99.7 1.0
CA A:LYS61 3.7 0.2 1.0
O A:GLY60 3.7 97.5 1.0
C15 A:3TA1 4.0 99.7 1.0
C7 A:3TA1 4.0 96.7 1.0
CA A:GLY60 4.2 0.2 1.0
CA A:GLY62 4.3 0.0 1.0
CB A:CYS67 4.5 97.1 1.0
C8 A:3TA1 4.5 97.9 1.0
N A:GLY60 4.8 99.8 1.0
OD2 A:ASP194 4.9 65.3 1.0

Reference:

M.O.Duffey, T.J.Vos, R.Adams, J.Alley, J.Anthony, C.Barrett, I.Bharathan, D.Bowman, N.J.Bump, R.Chau, C.Cullis, D.L.Driscoll, A.Elder, N.Forsyth, J.Frazer, J.Guo, L.Guo, M.L.Hyer, D.Janowick, B.Kulkarni, S.J.Lai, K.Lasky, G.Li, J.Li, D.Liao, J.Little, B.Peng, M.G.Qian, D.J.Reynolds, M.Rezaei, M.P.Scott, T.B.Sells, V.Shinde, Q.J.Shi, M.D.Sintchak, F.Soucy, K.T.Sprott, S.G.Stroud, M.Nestor, I.Visiers, G.Weatherhead, Y.Ye, N.D'amore. Discovery of A Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905). J.Med.Chem. V. 55 197 2012.
ISSN: ISSN 0022-2623
PubMed: 22070629
DOI: 10.1021/JM2011172
Page generated: Fri Jul 11 10:44:05 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy